Welcome to Multibagg AI
Log in to access personalized features
Portfolio
Alerts
Ask Iris
Discovery
Timeline
Multibagg AI is an AI powered stock research and analysis platform. We provide data, information, content, and analytics for publicly traded Indian companies listed on NSE and BSE. AI can make mistakes, check important information.
Prices might be delayed by a few minutes.
Join our Exclusive Community
Join our Exclusive Community
Made with 💙 in India. © Finsky Technologies Pvt Ltd. 2026
Get instant AI-powered insights about company performance, financials, and strategy. Ask questions about trends, competition, and developments while receiving responses backed by official documents and market data, with clear attribution to source documents.
Discovery themes featuring this stockBearish
5
Neutral
4
Bullish
5
Bearish
37
Neutral
4
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
5
Neutral
4
Bullish
5
Bearish
5
Neutral
4
Bullish
5
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Bearish
32
Neutral
0
Bullish
0
Roopa Industries Limited, part of the TGV Group, is a manufacturer and exporter of Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids, and Water Treatment Chemicals, with operations since 1985.
The company transitioned into producing Neutraceuticals, Fine chemicals, Drug Intermediates, and Bulk Drugs in 1998, serving a wide range of international clients.
Roopa Industries specializes in hazardous and intricate manufacturing processes, particularly known for its technical expertise in organic synthesis applications.
Key products include Active Pharmaceutical Ingredients like Fluconazole, Sildenafil Citrate, and several nutraceuticals such as Glucosamine salts, known for their therapeutic benefits in managing arthritis.
Their major export markets include Germany, the Netherlands, and Sri Lanka, which underscores their global market penetration.
Pharmaceuticals & Biotechnology
Pharmaceuticals
37 Cr
Moderate Risk
284.5
37.7
0.3
2.1
63.40
38.10
Sales CAGR
Profit CAGR
ROE
ROCE
| Symbol | Watchlist | Price | Market Cap | P/E | P/B | Div Yield (%) | ROE (%) | ROCE (%) | ROA (%) |
25.20 | 39 Cr | -9.81 | 1.03 | 0.00 | -13.99 | -10.62 | -7.79 | ||
45.83 | 37 Cr | 284.46 | 2.10 | 0.00 | 23.13 | 15.39 | 0.18 | ||
37.94 | 37 Cr | 23.53 | 1.10 | 0.00 | 3.69 | 5.32 | 2.80 | ||
5.89 | 36 Cr | -3.04 | 0.98 | 0.00 | -33.10 | -32.42 | -21.35 | ||
44.65 | 35 Cr | 11.63 | 1.07 | 0.00 | 9.20 | 12.30 | 3.24 | ||
14.05 | 35 Cr | -1.51 | 4.11 | 0.00 | -117.84 | -25.84 | -37.84 | ||
| Median: 6 Co. | — | 31.57 | 36 Cr | 5.06 | 1.08 | 0.00 | -5.15 | -2.65 | -3.80 |
Roopa Industries Ltd (ROOPAIND) is currently trading at 45.83 per share. Stock prices fluctuate during market hours on NSE and BSE based on demand, company updates, and overall market conditions. Refer to the live price chart above for the most recent price movement.
Roopa Industries Limited, part of the TGV Group, is a manufacturer and exporter of Chloro Alkali Products, Castor Oil Derivatives, Fatty Acids, and Water Treatment Chemicals, with operations since 1985. The company transitioned into producing Neutraceuticals, Fine chemicals, Drug Intermediates, and Bulk Drugs in 1998, serving a wide range of international clients. Roopa Industries specializes in hazardous and intricate manufacturing processes, particularly known for its technical expertise in organic synthesis applications. Key products include Active Pharmaceutical Ingredients like Fluconazole, Sildenafil Citrate, and several nutraceuticals such as Glucosamine salts, known for their therapeutic benefits in managing arthritis. Their major export markets include Germany, the Netherlands, and Sri Lanka, which underscores their global market penetration.
Over the past 52 weeks, Roopa Industries Ltd has traded between a low of ₹38.10 and a high of ₹63.40. The 52-week high and low indicate the stock’s price range over the last year and help investors understand its volatility and recent trading levels.
Roopa Industries Ltd has a market capitalization of approximately 36.98. Market capitalization represents the total value of a company’s outstanding shares and helps investors understand its size, stability, and relative risk compared to other listed companies.
Roopa Industries Ltd’s investment profile depends on its business fundamentals, valuation, and long-term outlook. The stock currently trades at a PE ratio of 284.46 and operates in the its sector sector. Investors typically assess financial performance, growth prospects, and individual risk tolerance before making investment decisions.
Based on its market capitalization of 36.98 Cr, Roopa Industries Ltd is classified as a Small Cap stock. Large-cap stocks are generally more stable, while mid-cap and small-cap stocks tend to offer higher growth potential along with higher price volatility.
Roopa Industries Ltd operates in the its sector sector. Sector classification matters because companies in the same sector are often affected by similar economic conditions, regulatory changes, and competitive dynamics, which can influence overall stock performance.
The Price-to-Earnings (PE) ratio of Roopa Industries Ltd is 284.46. The PE ratio compares a company’s share price to its earnings and is commonly used to assess valuation. Comparing the PE ratio with sector peers and historical levels provides better context.
